Selected research
Industry Research
Hemostatis and Tissue Sealing Agents Industry Research Report 2026
Market perspective
The global Hemostatis and Tissue Sealing Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hemostatis and Tissue Sealing Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hemostatis and Tissue Sealing Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hemostatis and Tissue Sealing Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hemostatis and Tissue Sealing Agents include Johnson & Johnson, Medtronic, Pfizer Inc., Smith & Nephew, Integra Life Sciences Corporation, HyperBranch Medical Technology, CryoLife Inc., Cohesion Technologies Inc and Cohera Medical Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hemostatis and Tissue Sealing Agents market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemostatis and Tissue Sealing Agents Market by Company
Johnson & Johnson
Medtronic
Pfizer Inc.
Smith & Nephew
Integra Life Sciences Corporation
HyperBranch Medical Technology
CryoLife Inc.
Cohesion Technologies Inc
Cohera Medical Inc.
C R Bard Inc.
Biomet Inc.
B Braun Medical Inc.
Advance Medical Solution (AMS) Group Plc.
Hemostatis and Tissue Sealing Agents Segment by Type
Topical Hemostat
Adhesive & Tissue Sealant
Hemostatis and Tissue Sealing Agents Segment by Application
Home Care Settings
Ambulatory Surgical Centers
Hospitals
Others
Hemostatis and Tissue Sealing Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatis and Tissue Sealing Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostatis and Tissue Sealing Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatis and Tissue Sealing Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemostatis and Tissue Sealing Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemostatis and Tissue Sealing Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemostatis and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Topical Hemostat
- Adhesive & Tissue Sealant
Applications
- Home Care Settings
- Ambulatory Surgical Centers
- Hospitals
- Others
Companies covered
- Johnson & Johnson
- Medtronic
- Pfizer Inc.
- Smith & Nephew
- Integra Life Sciences Corporation
- HyperBranch Medical Technology
- CryoLife Inc.
- Cohesion Technologies Inc
- Cohera Medical Inc.
- C R Bard Inc.
- Biomet Inc.
- B Braun Medical Inc.
- Advance Medical Solution (AMS) Group Plc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemostatis and Tissue Sealing Agents Market Size (2021-2032)
- 2.2.2 Global Hemostatis and Tissue Sealing Agents Sales (2021-2032)
- 2.2.3 Global Hemostatis and Tissue Sealing Agents Market Average Price (2021-2032)
- 2.3 Hemostatis and Tissue Sealing Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Topical Hemostat
- 2.3.3 Adhesive & Tissue Sealant
- 2.4 Hemostatis and Tissue Sealing Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Home Care Settings
- 2.4.3 Ambulatory Surgical Centers
- 2.4.4 Hospitals
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemostatis and Tissue Sealing Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemostatis and Tissue Sealing Agents Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Hemostatis and Tissue Sealing Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemostatis and Tissue Sealing Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemostatis and Tissue Sealing Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemostatis and Tissue Sealing Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemostatis and Tissue Sealing Agents, Product Type & Application
- 3.8 Global Manufacturers of Hemostatis and Tissue Sealing Agents, Established Date
- 3.9 Global Hemostatis and Tissue Sealing Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Medtronic
- 4.2.1 Medtronic Company Information
- 4.2.2 Medtronic Business Overview
- 4.2.3 Medtronic Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medtronic Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.2.5 Medtronic Recent Developments
- 4.3 Pfizer Inc.
- 4.3.1 Pfizer Inc. Company Information
- 4.3.2 Pfizer Inc. Business Overview
- 4.3.3 Pfizer Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.3.5 Pfizer Inc. Recent Developments
- 4.4 Smith & Nephew
- 4.4.1 Smith & Nephew Company Information
- 4.4.2 Smith & Nephew Business Overview
- 4.4.3 Smith & Nephew Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Smith & Nephew Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.4.5 Smith & Nephew Recent Developments
- 4.5 Integra Life Sciences Corporation
- 4.5.1 Integra Life Sciences Corporation Company Information
- 4.5.2 Integra Life Sciences Corporation Business Overview
- 4.5.3 Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.5.5 Integra Life Sciences Corporation Recent Developments
- 4.6 HyperBranch Medical Technology
- 4.6.1 HyperBranch Medical Technology Company Information
- 4.6.2 HyperBranch Medical Technology Business Overview
- 4.6.3 HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.6.5 HyperBranch Medical Technology Recent Developments
- 4.7 CryoLife Inc.
- 4.7.1 CryoLife Inc. Company Information
- 4.7.2 CryoLife Inc. Business Overview
- 4.7.3 CryoLife Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CryoLife Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.7.5 CryoLife Inc. Recent Developments
- 4.8 Cohesion Technologies Inc
- 4.8.1 Cohesion Technologies Inc Company Information
- 4.8.2 Cohesion Technologies Inc Business Overview
- 4.8.3 Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.8.5 Cohesion Technologies Inc Recent Developments
- 4.9 Cohera Medical Inc.
- 4.9.1 Cohera Medical Inc. Company Information
- 4.9.2 Cohera Medical Inc. Business Overview
- 4.9.3 Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.9.5 Cohera Medical Inc. Recent Developments
- 4.10 C R Bard Inc.
- 4.10.1 C R Bard Inc. Company Information
- 4.10.2 C R Bard Inc. Business Overview
- 4.10.3 C R Bard Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 C R Bard Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.10.5 C R Bard Inc. Recent Developments
- 4.11 Biomet Inc.
- 4.11.1 Biomet Inc. Company Information
- 4.11.2 Biomet Inc. Business Overview
- 4.11.3 Biomet Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Biomet Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.11.5 Biomet Inc. Recent Developments
- 4.12 B Braun Medical Inc.
- 4.12.1 B Braun Medical Inc. Company Information
- 4.12.2 B Braun Medical Inc. Business Overview
- 4.12.3 B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.12.5 B Braun Medical Inc. Recent Developments
- 4.13 Advance Medical Solution (AMS) Group Plc.
- 4.13.1 Advance Medical Solution (AMS) Group Plc. Company Information
- 4.13.2 Advance Medical Solution (AMS) Group Plc. Business Overview
- 4.13.3 Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Product Portfolio
- 4.13.5 Advance Medical Solution (AMS) Group Plc. Recent Developments
5 Global Hemostatis and Tissue Sealing Agents Market Scenario by Region
- 5.1 Global Hemostatis and Tissue Sealing Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemostatis and Tissue Sealing Agents Sales by Region: 2021-2032
- 5.2.1 Global Hemostatis and Tissue Sealing Agents Sales by Region: 2021-2026
- 5.2.2 Global Hemostatis and Tissue Sealing Agents Sales by Region: 2027-2032
- 5.3 Global Hemostatis and Tissue Sealing Agents Revenue by Region: 2021-2032
- 5.3.1 Global Hemostatis and Tissue Sealing Agents Revenue by Region: 2021-2026
- 5.3.2 Global Hemostatis and Tissue Sealing Agents Revenue by Region: 2027-2032
- 5.4 North America Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
- 5.4.1 North America Hemostatis and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.4.3 North America Hemostatis and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
- 5.5.1 Europe Hemostatis and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.5.3 Europe Hemostatis and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemostatis and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemostatis and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
- 5.7.1 South America Hemostatis and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.7.3 South America Hemostatis and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemostatis and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemostatis and Tissue Sealing Agents Sales by Type (2021-2032)
- 6.1.1 Global Hemostatis and Tissue Sealing Agents Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Hemostatis and Tissue Sealing Agents Revenue by Type (2021-2032)
- 6.2.1 Global Hemostatis and Tissue Sealing Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemostatis and Tissue Sealing Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemostatis and Tissue Sealing Agents Sales by Application (2021-2032)
- 7.1.1 Global Hemostatis and Tissue Sealing Agents Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Hemostatis and Tissue Sealing Agents Revenue by Application (2021-2032)
- 7.2.1 Global Hemostatis and Tissue Sealing Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemostatis and Tissue Sealing Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemostatis and Tissue Sealing Agents Value Chain Analysis
- 8.1.1 Hemostatis and Tissue Sealing Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemostatis and Tissue Sealing Agents Production Mode & Process
- 8.2 Hemostatis and Tissue Sealing Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemostatis and Tissue Sealing Agents Distributors
- 8.2.3 Hemostatis and Tissue Sealing Agents Customers
9 Global Hemostatis and Tissue Sealing Agents Analyzing Market Dynamics
- 9.1 Hemostatis and Tissue Sealing Agents Industry Trends
- 9.2 Hemostatis and Tissue Sealing Agents Industry Drivers
- 9.3 Hemostatis and Tissue Sealing Agents Industry Opportunities and Challenges
- 9.4 Hemostatis and Tissue Sealing Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst